CORONAVIRUS NEWS
Executive War College: ongoing virtual interactive sessions
Remarkable things are happening as laboratories and anatomical pathology groups answer the challenges of the SARS-CoV-2 pandemic and the need for greater numbers of virus tests. Despite shortages, laboratories are adding SARS-CoV-2 test capacity.- Coronavirus
Molecular transport medium optimised for molecular testing
PrimeStore MTM is a molecular transport medium that provides a ‘snapshot’ in time of a sample by preserving and stabilising DNA and RNA. This means that samples can be collected, transported, and processed safely and efficiently.- Coronavirus
Antibodies for SARS-CoV-2 virus detection
ViroStat has released a set of new monoclonal antibodies to the nucleocapsid of the SARS-CoV-2 virus. These five antibodies were selected from a group of 60 based on highest binding affinity and best ELISA pairing to detect native viral antigen.- Coronavirus
Winter multiplex virus detection kit
Pro-Lab Diagnostics has announced that final-stage clinical trials are underway on the VIASURE Winter Multiplex CFR kit, which is expected to achieve CE certification by the end of August. Preliminary data show excellent performance characteristics.- Coronavirus
Clinical validation of Adeptrix COVID-19 diagnostic test
Avacta Group, the developer of Affimer biotherapeutics and reagents, has begun work with the UK government’s CONDOR programme to evaluate and validate the high-throughput COVID-19 bead-assisted mass spectrometry (BAMS) assay developed with Adeptrix.- Coronavirus
Molecular transport medium for dual SARS-CoV-2 and influenza sampling
EKF Diagnostics has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range. PrimeStore MTM is a collection device that deactivates viruses.- Coronavirus
Production of Platelia SARS-CoV-2 Total Ab test accelerated
Bio-Rad Laboratories is accelerating production of its Platelia SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.- Coronavirus
Prepare for a winter COVID-19 peak, warns Academy of Medical Sciences
The UK must prepare now for a potential new wave of coronavirus infections this winter that could be more serious than the first, says a new report from the Academy of Medical Sciences.- Coronavirus
Novel sensors to detect SARS-CoV-2 coronavirus in waste water
Avacta Group, the developer of Affimer biotherapeutics and reagents, is collaborating with Integumen to evaluate recently generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in waste water.- Coronavirus
Increasing efficiency of coronavirus sampling kit production
Xebios Diagnostics manufactures high-quality, ready-to-use culture media for microbiological diagnostic applications, and is using DOSE IT to aliquot viral transport medium (VTM) into sterile screw-capped tubes to meet market demand.- Coronavirus
Equipment and reagents from Randox used in COVID-19 hospital in India
Randox Laboratories has installed an RX modena in a COVID-19 hospital in India, at the Netaji Subhash Chandra Bose Medical College in Madhya Pradesh state.- Coronavirus
Rapid lateral-flow antibody test for SARS-CoV-2
Significant efforts are being made to protect public health and prevent local, regional or national spikes in SARS-CoV-2 cases. Antibody testing can determine population seroconversion and aid epidemiological and public health decisions.- Coronavirus
Genes associated with high risk of severe COVID-19
Scientists from PrecisionLife have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled precision medicine platform to analyse the genomes of 929 patients who had a severe response to SARS-CoV-2.- Coronavirus
COVID-19: impact on the NTM patient
A free webinar on COVID-19 and the impact on the non-tuberculous mycobacteria (NTM) patient will be held on Wednesday, 8 July at 5.00 pm. Click on this news item for registration details.- Coronavirus
Una Health and Fortress Diagnostics partner with the DHSC
Una Health, a distributor of in vitro diagnostics (IVDs), and Fortress Diagnostics, a provider of IVDs, are partnering with the Department of Health & Social Care in the Real Time Assessment of Community Transmission (REACT) study into COVID-19.- Coronavirus
Use of digital pathology for remote diagnosis
Hamamatsu Photonics invites you to join a panel discussion with pathologist Dr Matthew Hanna and IT Manager Nikolas Stathonikos on Thursday 9 July 2020 (4.00 pm BST, 11.00 am EDT, 5.00 pm CET). Click on this item for the link to register.- Coronavirus
Haematology biomarkers for COVID-19 assessment: an HORIBA white paper
HORIBA UK, Medical has published a white paper entitled ‘COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients’. The paper provides a review of biomarkers that help in the assessment of COVID-19 severity.- Coronavirus
Update on SARS-CoV-2 rapid antigen test development
Avacta Group has announced that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been evaluated by Avacta’s partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data.- Coronavirus
Pipetting solutions to make SARS-CoV-2 extraction faster and easier
The SARS-CoV-2 pandemic has placed unprecedented pressure on research and diagnostic laboratories to process more samples more quickly. INTEGRA Biosciences offers a range of pipetting systems designed to speed up PCR-based screening workflows.- Coronavirus
Predictive sepsis test for coronavirus patients funded by MOD
Ploughshare Innovations, a Defence Science and Technology Laboratory (Dstl) spin-out firm, has funded the development of a revolutionary test that has the potential to predict whether coronavirus patients will develop sepsis before symptoms appear.- Coronavirus
